The Technical Analyst
Select Language :
Inari Medical Inc [NARI]

Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices

Inari Medical Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: SELL (auto-tracking)

Inari Medical Inc is listed at the  Exchange

1.22% $47.98

America/New_York / 28 mar 2024 @ 16:00


Inari Medical Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 2 780.95 mill
EPS: -0.0300
P/E: -1 599.33
Earnings Date: Apr 30, 2024
SharesOutstanding: 57.96 mill
Avg Daily Volume: 1.004 mill
RATING 2024-03-28
B
Neutral
RATINGS
Rating CashFlow: Strong Sell
Return On Equity: Neutral
Return On Asset: Buy
DE: Neutral
P/E: Strong Sell
Price To Book: Strong Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -1 599.33 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-7.20x
Company: PE -1 599.33 | industry: PE 222.16
DISCOUNTED CASH FLOW VALUE
$-40.91
(-185.27%) $-88.89
Date: 2024-03-29
Expected Trading Range (DAY)

$ 45.46 - 50.51

( +/- 5.26%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-18 Hoffman William Sell 27 492 Common Stock
2024-03-18 Hoffman William Sell 12 508 Common Stock
2024-03-12 Hill, Mitch C. Buy 6 000 Common Stock
2024-03-12 Hill, Mitch C. Sell 5 999 Common Stock
2024-03-12 Hill, Mitch C. Sell 1 Common Stock
INSIDER POWER
-28.56
Last 100 transactions
Buy: 339 157 | Sell: 645 748

Forecast: 16:00 - $47.89

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $47.89
Forecast 2: 16:00 - $47.89
Forecast 3: 16:00 - $47.89
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $47.98 (1.22% )
Volume 6.48 mill
Avg. Vol. 1.004 mill
% of Avg. Vol 644.99 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Inari Medical Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Inari Medical Inc

RSI

Intraday RSI14 chart for Inari Medical Inc

Last 10 Buy & Sell Signals For NARI

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:35sell$57.07N/AActive
Profile picture for
            Inari Medical Inc

NARI

Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism. It also offers FlowSaver; FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

Last 10 Buy Signals

Date Signal @
MXUSDMar 29 - 04:07$4.21
RETHUSDMar 29 - 04:043 905.62
ABTUSDMar 29 - 04:041.978
XU100.ISMar 29 - 04:03PTS9 101.28
DYDXUSDMar 29 - 04:003.39
^KLSEMar 29 - 03:46PTS1 536.68
WSTETHUSDMar 29 - 03:594 101.01
WANETHUSDMar 29 - 03:533 523.63
KUBUSDMar 29 - 03:532.73
WTAOUSDMar 29 - 03:53524.24

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.